# Infertility for NEET PG OBG: ICMR Female and Male Work-up, WHO 2021 Semen Values, Ovulation Induction, IVF/ICSI, ART Act and Surrogacy Act 2021

Source: https://tracknation.in/story/infertility-for-neet-pg-obg-icmr-female-and-male-work-up-who-2021-semen-values-ovulation-induction-ivf-icsi-art-act-and-surrogacy-act-2021 (TrackNation — free UPSC notes with PYQs)

> NEET PG Gynaecology: definition and when to start evaluation, ICMR female (TVS, AFC, HSG, AMH) and male (semen analysis, WHO 2021 reference values, azoospermia) work-up, treatment by tubal, ovulatory and uterine factor, letrozole vs clomiphene, IVF/ICSI and OHSS, and the ART (Regulation) and Surrogacy (Regulation) Acts 2021, with a diagram, hooks, vignette MCQs and cards.

## Start Here

🎯 **Exam priority: High.** *Expect: the 12/6-month rule, cumulative conception rates, first-line tests for each partner, WHO 2021
semen values, AFC/AMH cut-offs, which factor leads to IUI vs IVF/ICSI, letrozole vs clomiphene, OHSS, and the age limits and rules in the ART
and Surrogacy Acts.*

CBME mapping: **OG28**. Indian anchors: ICMR STWs on female (2022) and male (2025) infertility; ART (Regulation) Act 2021 and
Surrogacy (Regulation) Act 2021 (gazette texts).

*Definitions, tests, treatment by factor, and the ART and Surrogacy Acts. Drawn by TrackNation.*

## Definition and Who to Evaluate (ICMR, MSD)

- **Infertility** = no pregnancy after **12 months** of regular unprotected intercourse (women <35) or **6 months** (women
>35). Affects **up to 15%** of couples. Women **>35: expedited**, **>40: immediate** evaluation; also early if oligo/amenorrhoea,
known tubal/uterine disease, endometriosis, prior chemo/radiotherapy or suspected male factor.

- Natural conception (MSD): about **70% in 3 months, 80% in 6, 90% in 1 year**. Causes: sperm disorders 24–35%, ovulatory dysfunction
21–25%, tubal, endometriosis, uterine, unexplained. **Female age is the most important prognostic factor** (ICMR).

- **Evaluate both partners together** (ICMR male STW): the male factor is the sole cause in **20%** and contributes in another
**30%**.

## Female Work-up and Treatment (ICMR, MSD)

- **Essential**: transvaginal ultrasound (uterus, adnexa, **antral follicle count on day 2–5**) and **HSG** for tubal patency.
Optional: **AMH**, day 2/3 FSH/LH, **TSH, prolactin**, endometrial aspirate for **TB (AFB/PCR)**, viral markers, rubella.
Ovulation is confirmed by **mid-luteal progesterone ≥3 ng/ml** (MSD).

- **Poor ovarian reserve: AFC <5, AMH <1.2 ng/ml** → IVF/ICSI with own or donor oocytes.

- **Tubes patent + ovulation documented** → ovarian stimulation ± **IUI for 3–6 cycles**, then IVF. **Both tubes blocked** →
confirm by **laparoscopy with chromopertubation** → **IVF/ICSI**. **Hydrosalpinx** → salpingectomy or clipping, then IVF.

- **Anovulation** (commonest cause: polyendocrine metabolic ovarian syndrome, as MSD names it) → ovulation induction. MSD:
**letrozole** (aromatase inhibitor) is preferred by many and works better than clomiphene in obese women with this syndrome; clomiphene →
twins ~5%, OHSS ≤1%, never in pregnancy. Uterine factor (polyp, septum, adhesions, cavity-distorting fibroid) → hysteroscopic/laparoscopic
correction.

- **IVF** (MSD): stimulation → hCG trigger → **oocyte retrieval ~34 hours later** → fertilisation (**ICSI** if sperm are
abnormal) → embryo transfer. GnRH-agonist trigger lowers **OHSS** risk.

## Male Work-up (ICMR 2025)

- Causes: **pretesticular** (hypogonadotropic hypogonadism, sexual dysfunction), **testicular** (primary failure, cryptorchidism,
**varicocele**, tumours), **post-testicular** (congenital absence of vas, ejaculatory duct obstruction, post-vasectomy).

- **Semen analysis** (essential): **2 samples 2–4 weeks apart**, **1–3 days' abstinence**, delivered within an hour at room
temperature. **WHO 2021 lower reference limits**: volume **1.4 ml**, total count **39 million**, total motility **42%**,
progressive **30%**, morphology **4%**.

- **Azoospermia** must be confirmed on a **centrifuged pellet**; obstructive vs non-obstructive. No ejaculate → think
**retrograde ejaculation**/anejaculation. Extended tests: hormones, karyotype (Klinefelter), Y-microdeletion, CFTR (absent vas).

## ART Act and Surrogacy Act 2021

- **ART (Regulation) Act 2021 (No. 42)**: services for a **woman 21–50** and a **man 21–55**; sperm donors **21–55**;
oocyte donors **23–35**, **once in a lifetime**, **no more than 7 oocytes** retrieved; one donor's gametes to **only one couple**.
The child is the **biological child of the commissioning couple**; donors give up all parental rights. Advertising sex-selective ART:
**5–10 years** and a fine.

- **Surrogacy (Regulation) Act 2021 (No. 47)**: **altruistic only** — no payment beyond medical costs and insurance. Intending couple:
**married, wife 23–50, husband 26–55**, **no surviving child** (exceptions for a child with serious illness/disability), with a
**certificate of essentiality**. Surrogate: **ever-married, own child, 25–35 years**, **once in a lifetime**, **may not use her own
eggs**, insured for **36 months**. Commercial surrogacy rackets, advertising, exploitation, sale of embryos and sex selection: up to **10 years** and Rs 10 lakh.

## Traps the Examiner Sets

- Over 35: start evaluation after 6 months; over 40: at once.

- Test the man early — male factor is involved in about half of couples.

- Both tubes blocked → IVF, not IUI.

- A surrogate cannot donate her own egg; surrogacy is altruistic only.

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **Evaluation clock '12-6-0': under 35 wait 12, over 35 wait 6, over 40 wait 0** — timing

- 🧠 **WHO 2021 semen '1.4 – 39 – 42 – 4'** — semen

- 🧠 **Reserve '5 and 1.2': AFC under 5 or AMH under 1.2 = poor** — reserve

- 🧠 **ART Act ages '21-50 her, 21-55 him; egg donor 23-35, once, 7 eggs'** — ART

- 🧠 **Surrogacy '23-50 / 26-55 couple; 25-35 surrogate, once, never her own egg'** — surrogacy

## Rapid-Revision Cards

- 12 months (<35); 6 months (>35).

- Evaluate immediately.

- Up to 15% couples.

- 70/80/90% at 3/6/12 mo.

- Female age.

- Sole 20%; contributes 30%.

- Day 2–5.

- AFC <5; AMH <1.2.

- HSG; confirm laparoscopy.

- IVF/ICSI.

- Clip/remove before IVF.

- Progesterone ≥3 ng/ml.

- Letrozole.

- Twins ~5%; OHSS ≤1%.

- 34 h after hCG.

- 2 samples; 1–3 d abstinence.

- 1.4 ml; 39 M; 42%; 4%.

- Woman 21–50; man 21–55.

- 23–35; once; ≤7 oocytes.

- Wife 23–50; husband 26–55.

- 25–35; own child; once; no own eggs.

## Sources

*Facts in this article were checked against these documents.*

- Standard Treatment Workflows: Female Infertility (2022); Male Infertility (2025) — Indian Council of Medical Research / DHR, 2022–2025

- The Assisted Reproductive Technology (Regulation) Act, 2021 (No. 42 of 2021) — Ministry of Law and Justice, Gazette of India, 2021

- The Surrogacy (Regulation) Act, 2021 (No. 47 of 2021) — Ministry of Law and Justice, Gazette of India, 2021

- MSD Manual Professional: Overview of Infertility; Ovulatory Dysfunction; Assisted Reproductive Technologies — Merck & Co. (MSD Manuals), 2024–26 (link)

- Competency Based Undergraduate Curriculum, Vol III: Obstetrics & Gynaecology (OG28) — National Medical Commission, 2024

## Test Yourself: Practice Questions

Thirty questions in NEET PG style, most of them clinical vignettes.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** A 29-year-old woman has not conceived after 8 months of regular unprotected intercourse. Per ICMR/MSD

- (a) evaluation is usually started at 12 months

- (b) infertility is confirmed

- (c) start IVF now

- (d) test only the husband

**Answer: (a)** — 6 months if >35.

**Q2.** A 37-year-old has tried for 7 months without conceiving. Next:

- (a) start clomiphene blindly

- (b) reassure

- (c) start evaluation now (6-month rule over 35)

- (d) wait 1 more year

**Answer: (c)** — >40: immediate.

**Q3.** Cumulative natural conception within 1 year is about

- (a) 50%

- (b) 90%

- (c) 30%

- (d) 99%

**Answer: (b)** — 70% at 3 mo, 80% at 6.

**Q4.** Per ICMR, the single most important prognostic factor in female infertility is

- (a) BMI

- (b) parity

- (c) AMH alone

- (d) the woman's age

**Answer: (d)** — Caution box.

**Q5.** ICMR advises evaluating the male partner

- (a) simultaneously with the female partner

- (b) only after the woman is fully investigated

- (c) only if the woman is normal after 2 years

- (d) never

**Answer: (a)** — Male factor ~half.

**Q6.** The male factor is the sole cause of infertility in about

- (a) 90%

- (b) 60%

- (c) 20% of couples

- (d) 2%

**Answer: (c)** — Contributory in 30% more.

**Q7.** The antral follicle count is measured on

- (a) day 2–5 of the cycle

- (b) any day

- (c) day 21

- (d) day 14

**Answer: (a)** — TVS.

**Q8.** The essential first test of tubal patency per ICMR is

- (a) CT scan

- (b) colposcopy

- (c) hysterosalpingography

- (d) laparotomy

**Answer: (c)** — Laparoscopy confirms.

**Q9.** A woman has AFC 3 and AMH 0.8 ng/ml. This indicates

- (a) tubal block

- (b) PCOS

- (c) poor ovarian reserve — IVF with own or donor oocytes

- (d) normal reserve

**Answer: (c)** — AFC <5, AMH <1.2.

**Q10.** HSG shows both tubes blocked. Next per ICMR:

- (a) observe

- (b) clomiphene

- (c) IUI for 6 cycles

- (d) confirm with laparoscopic chromopertubation, then IVF/ICSI

**Answer: (d)** — IUI needs a patent tube.

**Q11.** Before IVF, a large hydrosalpinx should be

- (a) drained vaginally only

- (b) left alone

- (c) treated with antibiotics only

- (d) removed or clipped

**Answer: (d)** — ICMR.

**Q12.** With patent tubes and documented ovulation, ICMR suggests

- (a) laparotomy

- (b) ovarian stimulation ± IUI for 3–6 cycles

- (c) immediate IVF

- (d) nothing

**Answer: (b)** — Then IVF if failed.

**Q13.** In an infertile woman, genital TB is looked for by

- (a) endometrial aspirate for AFB/PCR

- (b) HSG only

- (c) semen culture

- (d) Pap smear

**Answer: (a)** — Optional test.

**Q14.** Ovulation is confirmed by a mid-luteal serum progesterone of at least

- (a) 3 ng/ml

- (b) 300 ng/ml

- (c) 0.3 ng/ml

- (d) 30 ng/ml

**Answer: (a)** — MSD.

**Q15.** For ovulation induction in an obese woman with polyendocrine metabolic ovarian syndrome (PCOS), MSD favours

- (a) tamoxifen

- (b) danazol

- (c) letrozole

- (d) clomiphene

**Answer: (c)** — More ovulation.

**Q16.** Clomiphene causes multiple (mostly twin) pregnancy in about

- (a) 5%

- (b) 0.01%

- (c) 25%

- (d) 50%

**Answer: (a)** — OHSS ≤1%.

**Q17.** In IVF, oocytes are retrieved after the hCG trigger at about

- (a) 72 hours

- (b) 4 hours

- (c) 7 days

- (d) 34 hours

**Answer: (d)** — Before ovulation.

**Q18.** ICSI is particularly indicated when

- (a) never

- (b) the woman is anovulatory only

- (c) tubes are blocked but sperm normal

- (d) sperm production is abnormal

**Answer: (d)** — Single sperm injected.

**Q19.** To reduce OHSS risk in a high-risk woman, the final trigger can be

- (a) oxytocin

- (b) clomiphene

- (c) a GnRH agonist instead of hCG

- (d) double-dose hCG

**Answer: (c)** — MSD.

**Q20.** For semen analysis ICMR advises

- (a) one sample after 10 days' abstinence

- (b) a sample kept overnight in a fridge

- (c) 2 samples 2–4 weeks apart after 1–3 days' abstinence

- (d) a blood test instead

**Answer: (c)** — Deliver within 1 h.

**Q21.** WHO 2021 lower reference limit for total sperm count is

- (a) 100 million

- (b) 5 million

- (c) 39 million per ejaculate

- (d) 15 million

**Answer: (c)** — Volume 1.4 ml.

**Q22.** WHO 2021 lower reference limit for normal morphology is

- (a) 30%

- (b) 4%

- (c) 14%

- (d) 50%

**Answer: (b)** — Motility 42%.

**Q23.** A semen report shows no sperm. Before labelling azoospermia

- (a) examine a centrifuged pellet

- (b) repeat in 1 year

- (c) start IVF

- (d) give testosterone

**Answer: (a)** — ICMR.

**Q24.** A man produces no semen sample despite orgasm. ICMR says consider

- (a) retrograde ejaculation

- (b) normal finding

- (c) varicocele

- (d) Klinefelter syndrome

**Answer: (a)** — Or anejaculation.

**Q25.** Under the ART Act 2021, ART services may be given to a woman aged

- (a) 18–45

- (b) any age

- (c) 25–55

- (d) above 21 and below 50

**Answer: (d)** — Man 21–55.

**Q26.** An oocyte donor under the ART Act must be

- (a) 23–35 years, donating once in her life, max 7 oocytes retrieved

- (b) 21–50, twice

- (c) 18–40, any number of times

- (d) any age with consent

**Answer: (a)** — One couple only.

**Q27.** A child born through ART with donor gametes is legally

- (a) the clinic's responsibility

- (b) the biological child of the commissioning couple

- (c) a ward of the state

- (d) the donor's child

**Answer: (b)** — Donor relinquishes rights.

**Q28.** Under the Surrogacy Act 2021, surrogacy in India must be

- (a) allowed for any single man

- (b) altruistic — no payment beyond medical expenses and insurance

- (c) allowed for foreigners freely

- (d) commercial with fixed fees

**Answer: (b)** — Commercial banned.

**Q29.** The intending couple for surrogacy must be married with the wife aged

- (a) any age

- (b) 25–35 and husband 25–40

- (c) 21–45 and husband 21–50

- (d) 23–50 and husband 26–55

**Answer: (d)** — No surviving child.

**Q30.** A woman offers to be a surrogate. She must be

- (a) aged 40 with no children

- (b) unmarried and 21

- (c) ever-married with her own child, aged 25–35, a surrogate only once, not using her own eggs

- (d) paid a fixed fee

**Answer: (c)** — 36 months insurance.

### Active Recall

From memory: define infertility and when to evaluate, list female and male tests with WHO 2021 semen values and reserve cut-offs, match each factor to its treatment, compare letrozole and clomiphene, outline IVF/ICSI, and state the main ART Act and Surrogacy Act rules.
